Application of multispectral imaging in quantitative immunohistochemistry study of breast cancer: a comparative study

Tumor Biology

Volumn 37, Issue 4, 2016, Pages 5013-5024

  Liu, Wen Lou ^a   Wang, Lin Wei ^a   Chen, Jia Mei ^a   Yuan, Jing Ping ^a   Xiang, Qing Ming ^a   Yang, Gui Fang ^a   Qu, Ai Ping ^b   Liu, Juan ^b   Li, Yan ^a,c  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Immunohistochemistry; Invasive breast cancer; Multispectral imaging; Optical density; Quantitative image analysis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; CYTOKERATIN 5; ERBB2 PROTEIN, HUMAN; ESTROGEN RECEPTOR ALPHA; TUMOR MARKER;

ADULT; ARTICLE; BREAST CANCER; CANCER GRADING; CLINICAL FEATURE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE QUALITY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE DIAGNOSIS; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; AGED; BIOSYNTHESIS; BREAST TUMOR; DIAGNOSTIC IMAGING; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; MOLECULAR IMAGING; PATHOLOGY; PROCEDURES;

ADULT; AGED; BIOMARKERS, TUMOR; BREAST NEOPLASMS; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-5; MIDDLE AGED; MOLECULAR IMAGING; RECEPTOR, ERBB-2;

EID: 84946125590     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-4327-9     Document Type: Article

References (33)

1. Cregger M, Berger AJ, Rimm DL. Immunohistochemistry and quantitative analysis of protein expression. Arch Pathol Lab Med. 2006;130:1026–30.
2. Di Cataldo S, Ficarra E, Macii E. Computer-aided techniques for chromogenic immunohistochemistry: status and directions. Comput Biol Med. 2012;42:1012–25.
3. Tani S, Fukunaga Y, Shimizu S, Fukunishi M, Ishii K, Tamiya K. Color standardization method and system for whole slide imaging based on spectral sensing. Anal Cell Pathol (Amst). 2012;35:107–15.
4. Van der Loos CM. Chromogens in multiple immunohistochemical staining used for visual assessment and spectral imaging: the colorful future. J Histotechnol. 2010;33:31–40.
5. Stack EC, Wang C, Roman KA, Hoyt CC. Multiplexed immunohistochemistry, imaging, and quantitation: a review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis. Methods. 2014;70:46–58.
6. Blenman KR, Lee PP. Quantitative and spatial image analysis of tumor and draining lymph nodes using immunohistochemistry and high-resolution multispectral imaging to predict metastasis. Methods Mol Biol. 2014;1102:601–21.
7. Mansfield JR. Cellular context in epigenetics: quantitative multicolor imaging and automated per- cell analysis of miRNAs and their putative targets. Methods. 2010;52:271–80.
8. Xu X, Gimotty PA, Guerry D, et al. Lymphatic invasion revealed by multispectral imaging is common in primary melanomas and associates with prognosis. Hum Pathol. 2008;39:901–9.
9. Levenson RM, Mansfield JR. Multispectral imaging in biology and medicine: slices of life. Cytometry A. 2006;69:748–58.
10. Themelis G, Yoo JS, Ntziachristos V. Multispectral imaging using multiple-band pass filters. Opt Lett. 2008;33:1023–5.
11. Levenson RM, Fornari A, Loda M. Multispectral imaging and pathology: seeing and doing more. Expert Opin Med Diagn. 2008;2:1067–81.
12. Fiore C, Bailey D, Conlon N, et al. Utility of multispectral imaging in automated quantitative scoring of immunohistochemistry. J Clin Pathol. 2012;65:496–502.
13. Huang W, Hennrick K, Drew S. A colorful future of quantitative pathology: validation of Vectra technology using chromogenic multiplexed immunohistochemistry and prostate tissue microarrays. Hum Pathol. 2013;44:29–38.
14. Chen C, Xia HS, Gong YP, et al. The quantitative detection of total HER2 load by quantum dots and the identification of a new subtype of breast cancer with different 5-year prognosis. Biomaterials. 2010;31:8818–25.
15. Yuan JP, Wang LW, Qu AP, et al. Quantum dots-based quantitative and in situ multiple imaging on ki67 and cytokeratin to improve ki67 assessment in breast cancer. PLoS One. 2015;10:e0122734.
16. Wang LW, Qu AP, Yuan JP, et al. Computer-based image studies on tumor nests mathematical features of breast cancer and their clinical prognostic value. PLoS One. 2013;8:e82314.
17. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010.
18. Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ. WHO classification of tumours of the breast. World Health Organization classification of tumours. 4th ed. Lyon: IARC Press; 2012.
19. Peng CW, Liu XL, Liu X, Li Y. Co-evolution of cancer microenvironment reveals distinctive patterns of gastric cancer invasion: laboratory evidence and clinical significance. J Transl Med. 2010;8:101.
20. Hammond ME, Hayes DF, Dowsett M, et al. American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010;28:2784–95.
21. Wolff AC, Hammond ME, Hicks DG, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol. 2013;31:3997–4013.
22. Chen C, Peng J, Xia HS, et al. Quantum dots-based immunofluorescence technology for the quantitative determination of HER2 expression in breast cancer. Biomaterials. 2009;30:2912–8.
23. Kobayashi T, Iwaya K, Moriya T, et al. A simple immunohistochemical panel comprising 2 conventional markers, Ki67 and p53, is a powerful tool for predicting patient outcome in luminal-type breast cancer. BMC Clin Pathol. 2013;13:5.
24. Nuance™ 3.0 Quick Start Guide. P/N 130805 Rev. 00. Caliper Life Sciences, Inc., 68 Elm St., Hopkinton, MA, 01748, USA 508-435-9500. www.CaliperLS.com.
25. Van der Loos CM. Multiple immunoenzyme staining: methods and visualizations for the observation with spectral imaging. J Histochem Cytochem. 2008;56:313–28.
26. Boucheron LE, Bi Z, Harvey NR, Manjunath B, Rimm DL. Utility of multispectral imaging for nuclear classification of routine clinical histopathology imagery. BMC Cell Biol. 2007;8 Suppl 1:S8.
27. Wu X, Amrikachi M, Shah SK. Embedding topic discovery in conditional random fields model for segmenting nuclei using multispectral data. IEEE Trans Biomed Eng. 2012;59:1539–49.
28. McNutt NS, Levenson RM, Peters SB. Spectral imaging microscopy reveals nuclear eosinophilia in hyperchromatic nuclei of mycosis fungoides and other disorders. Am J Dermatopathol. 2005;27:532.
29. Taylor CR, Levenson RM. Quantification of immunohistochemistry-Issues concerning methods, utility and semiquantitative assessment II. Histopathology. 2006;49:411–24.
30. Levenson R, Beechem J, McNamara G. Spectral imaging in preclinical research and clinical pathology. Stud Health Technol Inform. 2013;185:43–75.
31. Maeda T, Nakanishi Y, Hirotani Y, et al. Immunohistochemical co-expression status of cytokeratin 5/6, androgen receptor, and p53 as prognostic factors of adjuvant chemotherapy for triple negative breast cancer. Med Mol Morphol. 2015. doi:10.1007/s00795-015-0109-0.
32. Badve S, Nakshatri H. Oestrogen-receptor-positive breast cancer: towards bridging histopathological and molecular classifications. J Chin Pathol. 2009;62:6–12.
33. Wang Z, Bovik AC, Sheikh HR, Simoncelli EP. Image quality assessment: from error visibility to structural similarity. IEEE Trans Image Process. 2004;13:600–12.